Mark Da-Jian Chen

Class Action Complaint in MW Gestion, described as "an institutional asset manager based in France" v. Global Cord Blood Corporation, described as a Cayman Islands-domiciled, Hong Kong-based company that "provides umbilical cord blood storage and ancillary services in the in the Beijing Municipality, Guangdong Province, and Zhejiang Province of the People’s Republic of China"; Ting Zheng, Bing Chuen, a.k.a. Albert Chen; Yuen Kam, Mark Da-Jian Chen, Jennifer J. Weng, Ken Lu, Jack Chow, Jacky Cheng, Golden Meditech Holdings Limited, of the Cayman Islands; Golden Meditech Stem Cells (BVI) Company Limited, of the British Virgin Islands; GM Precision Medicine (BVI) Limited, of the British Virgin Islands; Golden Meditech Precision Medicine Limited, of Hong Kong; Golden Meditech (BVI) Company Limited, of the British Virgin Islands, and KPMG Huazhen LLP at the U.S. District Court for the Southern District of New York.

Complaint "to recoup the substantial funds - at least hundreds of millions of dollars - that insiders brazenly stole from Global Cord Blood" in MW Gestion and MW Optimum, derivatively and on behalf of nominal defendant Global Cord Blood Corporation, of the Cayman Islands v. Golden Meditech Holdings Limited, of the Cayman Islands; Ting (Tina) Zheng, Albert Chen, Yuen Kam, Mark Da-Jian Chen, Jennifer J. Weng, Ken Lu, Jack Chow, Jacky Cheng, all of Hong Kong; Celenkos Inc., of Delaware; Golden Meditech Stem Cells (BVI) Company Limited, GM Precision Medicine (BVI) Limited, of the British Virgin Islands; Golden Meditech (BVI) Company Limited, all of the British Virgin Islands; Easton Capital Corp., and Redwood Valuation Partners, both of New York, USA, at the Supreme Court of the State of New York, County of New York.